In this newsletter we talk about eight of our investees:
- Novartis acquires Uniseed investee company, Spinifex Pharmaceuticals, for US$200m plus milestone payments.
- Hatchtech M&A process to commercialize Xeglyze™ lotion.
- Verva signs deals with two private biotechnology companies.
- Otifex begins Phase 1b clinical study.
- Hydrexia $4.25m investment for its hydrogen storage technology.
- Progel launches novel probiotic drinks.
- OccuRx launched with up to $6.5m in funding.
- Tenasitech secures $509,269 Federal grant.
Click here to download your copy.
